Cibus, Inc.

CBUS

NASDAQ

Healthcare

Biotechnology

San Diego, CA, US157 employeescibus.com

$1.97

+0.04(1.92%)

Mkt Cap $89M

$1.16

$4.05

52-Week Range

At a Glance

AI-generated

8-K

Cibus, Inc. entered into an underwriting agreement with BTIG, LLC for a public offering of 6,976,744 shares of its Class A common stock at $2.15 per share, with an option for the underwriter to purchase up to an additional 1,046,511 shares, expected to generate net proceeds of approximately $13.5 million.

$89M

Market Cap

$361.8K

Revenue

-$13M

Net Income

Employees157

Fundamentals

How The Business Makes Money

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

Industry Biotechnology

Activity

What Changed Recently

Other Event

Mar 26, 2026

Other Events. On March 25, 2026, Cibus, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BTIG, LLC, as the sole u

Other Event

Jan 29, 2026

Other Events. On January 29, 2026, Cibus, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BTIG, LLC, as the sole

Other Event

Jan 27, 2026

. Other Events. In connection with its underwritten offering announced today, Cibus, Inc. (“Cibus” or the “Company”) is providing the following disclosures, whi

Other Event

Jan 5, 2026

. Other Events. On December 31, 2025, Cibus, Inc. (the “Company”) purchased 60,088 shares of Class A common stock, par value $0.0001 per share, of the Company f

Peer Companies

Company	Price	Change	Market Cap	P/E
RLMDRelmada Therapeutics, Inc...	$7.00	-1.41%	$513M	-7.0
VXRTVaxart, Inc.	$0.62	+1.61%	$150M	10.2
UNCYUnicycive Therapeutics, I...	$6.96	-2.32%	$149M	-3.7
RPTXRPTX	$2.65	+0.00%	$114M	—
IMUXImmunic, Inc.	$1.15	-0.43%	$113M	-18.7
CAMPCAMP4 Therapeutics Corpor...	$4.45	-0.34%	$94M	-3.0
BMEABiomea Fusion, Inc.	$1.53	+3.02%	$91M	-0.5
PMVPPMV Pharmaceuticals, Inc.	$1.33	+0.38%	$71M	-1.0

Analyst View

Company Profile

CIK0001705843

ISINUS17166A1016

CUSIP17166A101

Phone858 450 0008

Address6455 Nancy Ridge Drive, San Diego, CA, 92121, US

SEC EDGAR